Session: Innovation Showcase: Puppies Appreciate GastroPlus How Model-Informed Drug Development Can Reduce & Focus Clinical Trials Through Simulation
Innovation Showcase Puppies Appreciate GastroPlus How Model-Informed Drug Development Can Reduce & Focus Clinical Trials Through Simulation
Tuesday, July 9, 2024
6:00 PM – 7:30 PM CET
Location: Sala Europa
Sponsored By
Model-informed drug development (MIDD) offers an accelerated path to characterize release profiles for drugs delivered through ocular, pulmonary, dermal/subq, IM, IA as well as gastrointestinal administration routes—which increases understanding, safety and efficacy while reducing costs. In this presentation, Senior Director of Business Development Dan O’Connor will highlight the newly released GastroPlus® X platform, which is revolutionizing in silico modeling and helping scientists achieve their goals!
